(Q73507340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Hydroxyurea chemotherapy for unresectable or residual meningioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

H B Newton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M A Slivka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Stevens

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

165-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11206012%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1026770624783

4 November 2019

exact match

0 references

cites work

Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors

1 reference

12 December 2020

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

1 reference

12 December 2020

Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators

1 reference

12 December 2020

Mifepristone (RU 486) treatment of meningiomas

1 reference

12 December 2020

The role of radiotherapy in the treatment of subtotally resected benign meningiomas

1 reference

12 December 2020

Epidemiology of intracranial meningioma

1 reference

12 December 2020

Average relative dose intensity and the impact on design of clinical trials.

1 reference

12 December 2020

Long-term outcomes after meningioma radiosurgery: physician and patient perspectives

1 reference

12 December 2020

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

1 reference

12 December 2020

Management of benign and aggressive intracranial meningiomas.

1 reference

12 December 2020

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy

1 reference

12 December 2020

Incidence and clinicopathological features of meningioma.

1 reference

12 December 2020

Perspective: the chemotherapeutic relevance of apoptosis and a proposed biochemical cascade for chemotherapeutically induced apoptosis

1 reference

12 December 2020

Meningioma: analysis of recurrence and progression following neurosurgical resection

1 reference

12 December 2020